GemSeek wishes all of you to stay ahead of the game in the year to come
Customer Experience, as a source of competitive advantage, is on the rise. How do we know? We asked managers and executives in marketing, sales, and customer experience from more than 20 industries in our Annual CX Trends survey. Even though only 4 out of 10 organizations currently use CX to stay ahead of the game, this is half as many as they were 3 years ago. The share of organizations that compete based on CX is expected to jump another 54% in the next 3 years.
Now that we have these and other CX trends results, we carefully wrapped them in CXmas spirit and we are ready to present them to you together with our warmest wishes for the holiday season!
How can you get the full survey report?
Everyone who filled out the survey will be sent the full report – after all, we couldn’t have done it without your input! You will receive a thorough analysis of the results, discussing the trends, tools, and organizational practices in the various industries.
If you did not participate, but still want access, fear not – we have decided to leave the survey open until the end of January, so more professionals can receive insights for their industries. You can access it here
Got questions? Get in touch and one of our experts will contact you with customized advice!
With RSNA 2019 around the corner, it is time to peak into the recent developments in healthcare and the medical technology industry in particular. Pressed by increasing investor expectations and struggling to commercialize AI solutions, these are some of the main strategic directions that MedTech executives have taken to drive business growth.
Expansion to an Entire Clinical Area
A number of MedTech M&A deals from 2019 indicate that companies are seeking an additional competitive advantage by expanding their capabilities in strategic areas. Pressed by the ever-increasing investor expectations, many are entering adjacent fields in order to cover an entire clinical area. Some examples in this direction are adding interventional oncology to traditional oncology propositions, or enhancing interventional oncology portfolios with new applications.
Bringing AI/ML Innovations to Market
While a lot of industries are betting on AI to solve long-standing issues in their fields, in healthcare data science technologies literally have the potential to save and change lives. That’s why MedTech vendors have doubled their efforts to take their AI developments from the phases of research and prototyping to viable commercial products. Multiple partnerships and incubator programs have been set up between large original equipment manufacturers (OEMs) like Philips, Siemens Healthineers, GE Healthcare and smaller innovative startup companies or health IT vendors.
Stepping into Integrated Diagnostics by Merging Radiomics, Genomics & Pathology
This is a budding field with the potential to bridge the gap between diagnostic disciplines and improve patient outcomes. Already data science technologies exist which can enhance significantly a diagnostic system that integrates data from imaging, genomics, laboratory medicine and pathology. The integration of smart data will advance Precision Medicine – a promising area which is gaining traction with the advancements in data science.
Curious to learn more?
Sign up below and get a detailed report of the exciting developments in medtech – the biggest mergers & acquisitions, promising partnerships with AI startups and the recent developments of innovative integrated diagnostics.